Tetanus antitoxin. 1968

W H Crichton

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus

Related Publications

W H Crichton
July 1911, California state journal of medicine,
W H Crichton
February 1964, The Medical journal of Australia,
W H Crichton
September 1992, North Carolina medical journal,
W H Crichton
April 1963, British medical journal,
W H Crichton
January 1968, British medical journal,
W H Crichton
January 1967, New York state journal of medicine,
W H Crichton
January 1951, Annals of allergy,
W H Crichton
April 1973, JAMA,
W H Crichton
July 1973, JAMA,
W H Crichton
February 1901, The Hospital,
Copied contents to your clipboard!